CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial
Aryun Kim, Young Eun Kim, Ji Young Yun, Han-Joon Kim, Hui-Jun Yang, Woong-Woo Lee, Chae Won Shin, Hyeyoung Park, Yu Jin Jung, Ahro Kim, Yoon Kim, Mihee Jang, Beomseok Jeon
JMD. 2018;11(2):65-71.   Published online 2018 May 30    DOI:

Excel Download

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial
Journal of Movement Disorders. 2018;11(2):65-71   Crossref logo
Link1 Link2 Link3

EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease
Journal of Parkinson's Disease. 2020;10(2):543-558   Crossref logo

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study
Journal of Parkinson's Disease. 2017;7(3):511-522   Crossref logo

ADS-5102 provided reduction in motor complications in Parkinson’s disease patients with levodopa-induced dyskinesia switched from amantadine IR: Subgroup analysis from open-label study (ease LID 2)
Journal of the Neurological Sciences. 2017;381:355   Crossref logo
Link1 Link2

Amantadine for dyskinesia in patients affected by severe Parkinson's disease
Neurological Sciences. 2001;22(1):75-76   Crossref logo
Link1 Link2 Link3

Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open‐label ADS‐5102
Movement Disorders Clinical Practice. 2018;5(2):183-190   Crossref logo
Link1 Link2 Link3 Link4

Early intervention in parkinson’s disease with cabergoline – Results of an open-label long-term trial with focus on sleep disturbances
Clinical Neurophysiology. 2007;118(4):e53   Crossref logo
Link1 Link2

Tolcapone in elderly patients with Parkinson’s disease: A prospective open-label multicenter non-interventional trial
Archives of Gerontology and Geriatrics. 2009;49(1):e40-e44   Crossref logo
Link1 Link2

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
Movement Disorders. 2015;30(6):788-795   Crossref logo
Link1 Link2 Link3

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease
Therapeutics and Clinical Risk Management. 2018;Volume 14:665-673   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. JMD has participated in CrossRef Text and Data Mining service since October 29, 2014.